Research analysts covering Advanced Micro Devices, Inc. (NASDAQ:AMD) are projecting that the shares reach $12.09 within the next 12-18 months. This is the consensus number derived from the 11 analyst reports taken into consideration. The most bullish, or aggressive analyst target pins the projected price at $17, while the most bearish, or conservative analyst sees the stock reaching $5.
Broker Rating Update on Advanced Micro Devices, Inc. (NASDAQ:AMD)
Zacks provides analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations. Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) currently have an ABR of 2. This is based on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Moving to earnings estimates, for this current fiscal period, Wall Street analysts have projected that the company will post $-0.07 earnings per share. This is the current Zacks consensus EPS which was calculated at the time of writing. Analysts will likely revise their estimates leading in to the actual results date.
taking a look at the most recent period, which closed on 2016-12-31, Advanced Micro Devices, Inc. reported EPS of $-0.04 for a surprise factor of 0%, calculated by being $0 away from analyst projections.
Investors will be marking their calendars for 2017-05-01, when the company is planning to release their quarterly results.
For the current quarter, analysts are expecting Medtronic, Inc. (NYSE:MDT) to report EPS of $1.31. This consensus estimate is provided by Zacks Research. After the period that ended on 2017-01-31, Medtronic, Inc. (NYSE:MDT) reported an EPS actual of $1.12. The difference between the actual and estimate resulted in a surprise factor of 0.9%. The company is expected to release their next earnings report on or around 2017-05-30. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.
Shares of Medtronic, Inc. (NYSE:MDT) have a current ABR or average broker rating of 1.95. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.
Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Medtronic, Inc. (NYSE:MDT) is $87.437. The top analyst target is $96, and the lowest target is $80 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.